Pages that link to "Q37366616"
Jump to navigation
Jump to search
The following pages link to Vascular dysfunction induced by elevated glucose levels in rats is mediated by vascular endothelial growth factor. (Q37366616):
Displaying 50 items.
- Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition (Q28343572) (← links)
- Glucose, VEGF-A, and diabetic complications (Q28362039) (← links)
- Endogenous VEGF is required for visual function: evidence for a survival role on müller cells and photoreceptors (Q33382103) (← links)
- Autocrine and paracrine mechanisms in the early stages of diabetic nephropathy (Q33793187) (← links)
- Glycochelates and the etiology of diabetic peripheral neuropathy (Q33864190) (← links)
- The pathogenesis of early retinal changes of diabetic retinopathy (Q34149599) (← links)
- The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society (Q34292435) (← links)
- Retracted: The Nexus between VEGF and NFκB Orchestrates a Hypoxia-Independent Neovasculogenesis (Q34637708) (← links)
- Diabetic vascular dysfunction: links to glucose-induced reductive stress and VEGF. (Q34733351) (← links)
- Pilot study of Doppler optical coherence tomography of retinal blood flow following laser photocoagulation in poorly controlled diabetic patients. (Q34940374) (← links)
- Paradoxes of nitric oxide in the diabetic kidney (Q35123478) (← links)
- Role of VEGF in kidney development, microvascular maintenance and pathophysiology of renal disease (Q35181953) (← links)
- Polymorphisms in the vascular endothelial growth factor gene and the risk of diabetic retinopathy in Chinese patients with type 2 diabetes. (Q35600012) (← links)
- Vascular endothelial growth factor antagonist modulates leukocyte trafficking and protects mouse livers against ischemia/reperfusion injury (Q35607191) (← links)
- Metabolic changes in type 2 diabetes are reflected in peripheral blood cells, revealing aberrant cytotoxicity, a viral signature, and hypoxia inducible factor activity (Q35625640) (← links)
- Expression of vascular endothelial growth factor in the human retina and in nonproliferative diabetic retinopathy. (Q35765120) (← links)
- Experimental diabetes causes breakdown of the blood-retina barrier by a mechanism involving tyrosine nitration and increases in expression of vascular endothelial growth factor and urokinase plasminogen activator receptor (Q35791512) (← links)
- Vascular endothelial growth factor (VEGF)-induced retinal vascular permeability is mediated by intercellular adhesion molecule-1 (ICAM-1). (Q35810089) (← links)
- Roles for VEGF in the adult. (Q36248647) (← links)
- Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF). (Q36346473) (← links)
- Diabetic neuropathy and oxidative stress (Q36408693) (← links)
- Hyperglycemia-induced reactive oxygen species toxicity to endothelial cells is dependent on paracrine mediators (Q36756478) (← links)
- VEGF levels in plasma in relation to platelet activation, glycemic control, and microvascular complications in type 1 diabetes. (Q36868343) (← links)
- Erianin inhibits high glucose-induced retinal angiogenesis via blocking ERK1/2-regulated HIF-1α-VEGF/VEGFR2 signaling pathway (Q37291255) (← links)
- Vascular dysfunction in the diabetic placenta: causes and consequences. (Q37534948) (← links)
- Possible effects of glimepiride beyond glycemic control in patients with type 2 diabetes: a preliminary report (Q37541529) (← links)
- New insights into molecular mechanisms of diabetic kidney disease (Q37598306) (← links)
- The evolving story of the RAAS in hypertension, diabetes and CV disease: moving from macrovascular to microvascular targets (Q37611981) (← links)
- The Increased Circulating Plasma Levels of Vascular Endothelial Growth Factor in Patients with Type 1 Diabetes Do Not Correlate to Metabolic Control (Q37736405) (← links)
- The NAD ratio redox paradox: why does too much reductive power cause oxidative stress? (Q38068910) (← links)
- Transcription factors Sp1 and Sp3 alter vascular endothelial growth factor receptor expression through a novel recognition sequence (Q38335452) (← links)
- Effects of reducing the lactate and glucose content of PD solutions on the peritoneum. Is the future GLAD? (Q38487275) (← links)
- Aldose reductase inhibitor ameliorates renal vascular endothelial growth factor expression in streptozotocin-induced diabetic rats (Q39979855) (← links)
- Proinflammatory functions of vascular endothelial growth factor in alloimmunity (Q40271475) (← links)
- Effect of D-glucose on nitric oxide release from glomerular endothelial cells (Q40796622) (← links)
- Effects of high glucose on vascular endothelial growth factor expression in vascular smooth muscle cells (Q41075067) (← links)
- VEGF-A regulates the expression of VEGF-C in human retinal pigment epithelial cells (Q41863378) (← links)
- MicroRNA-152 represses VEGF and TGFβ1 expressions through post-transcriptional inhibition of (Pro)renin receptor in human retinal endothelial cells (Q41899278) (← links)
- The MicroRNA-21 signaling pathway is involved in prorenin receptor (PRR) -induced VEGF expression in ARPE-19 cells under a hyperglycemic condition (Q42290908) (← links)
- Early neural and vascular dysfunctions in diabetic rats are largely sequelae of increased sorbitol oxidation (Q42917615) (← links)
- Increased retinal endothelial cell monolayer permeability induced by the diabetic milieu: role of advanced non-enzymatic glycation and polyol pathway activation. (Q43834022) (← links)
- Influence of glucose and insulin on transcapillary fluid absorption from the arm during lower body negative pressure in man. (Q44507297) (← links)
- Plasma and urinary vascular endothelial growth factor and diabetic nephropathy in Type 2 diabetes mellitus (Q44904255) (← links)
- Simvastatin alleviates diabetes-induced VEGF-mediated nephropathy via the modulation of Ras signaling pathway (Q46526929) (← links)
- A neutralizing VEGF antibody prevents glomerular hypertrophy in a model of obese type 2 diabetes, the Zucker diabetic fatty rat. (Q46774459) (← links)
- Collagen ultrastructure and TGF-beta1 expression preserved with aminoguanidine during wound healing in diabetic rats (Q46879113) (← links)
- Bowman Lecture 1998. Diabetic retinopathy: some cellular, molecular and therapeutic considerations (Q48580864) (← links)
- Increased H2O2, vascular endothelial growth factor and receptors in the retina of the BBZ/Wor diabetic rat. (Q52537902) (← links)
- Consumption of polyphenol-rich Morus alba leaves extract attenuates early diabetic retinopathy: the underlying mechanism. (Q53766666) (← links)
- Insulin therapy improves islet functions by restoring pancreatic vasculature in high-fat diet-fed streptozotocin-diabetic rats. (Q54353931) (← links)